1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Mild-to-moderate and moderate-to-severe group physiologic parameters before and after spasmolytic therapy along with percentage improvement in PbO2 after spasmolytic therapy
Vasospasm Severity Timing PbO2a (mm Hg ± SE) CPPb (mm Hg ± SE) ICPb (mm Hg ± SE) SaO2b (mm Hg ± SE) Fio2b (mm Hg ± SE) % PbO2 Improvement Mild-mod Prespasmolysis 35.2 ± 3.1 110.9 ± 3.5 5.4 ± 2.2 99.6 ± 0.3 55.7 ± 3.5 14 Postspasmolysis 40.3 ± 3.1 107.9 ± 4.0 4.6 ± 1.0 99.5 ± 0.3 55.5 ± 4.1 Mod-sev Prespasmolysis 27.3 ± 3.1 116.7 ± 3.8 5.8 ± 1.3 99.8 ± 0.2 57.5 ± 6.1 40 Postspasmolysis 38.4 ± 3.2 113.9 ± 4.4 7.8 ± 1.9 99.2 ± 0.5 57.0 ± 6.1